LEADER 01661nam  2200541 a 450 
001 9910463228703321
005 20200520144314.0
010   $a1-62417-312-8
035   $a(CKB)2670000000370436
035   $a(EBL)3022180
035   $a(SSID)ssj0001188950
035   $a(PQKBManifestationID)11674453
035   $a(PQKBTitleCode)TC0001188950
035   $a(PQKBWorkID)11140681
035   $a(PQKB)11195526
035   $a(MiAaPQ)EBC3022180
035   $a(Au-PeEL)EBL3022180
035   $a(CaPaEBR)ebr10693645
035   $a(OCoLC)923667654
035   $a(EXLCZ)992670000000370436
100   $a20121022d2013      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aVasopressin$b[electronic resource] $emechanisms of action, physiology and side effects /$fLeonzio Galella, editor
210   $aNew York $cNovinka$d2013
215   $a1 online resource (127 p.)
225 1 $aNeuroscience research progress
225 1 $aEndocrinology research and clinical developments
300   $aDescription based upon print version of record.
311   $a1-62417-311-X 
320   $aIncludes bibliographical references and index.
410  0$aNeuroscience research progress series.
410  0$aEndocrinology research and clinical developments.
606   $aVasopressin
608   $aElectronic books.
615  0$aVasopressin.
676   $a612.492
701   $aGalella$b Leonzio$0920703
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910463228703321
996   $aVasopressin$92064918
997   $aUNINA